VRAX icon

Virax Biolabs
VRAX

Overview Fund Trends Analyst Outlook Journalist POV

2 hedge funds and large institutions have $28.6K invested in Virax Biolabs in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
2
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$13.6K
2
+$3.95K

Top Sellers

1
-$25.6K
2
-$15.5K
3
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$24.7K
National Bank of Canada
2
National Bank of Canada
Quebec, Canada
$3.95K
UBS Group
3
UBS Group
Switzerland
–
TSS
4
Two Sigma Securities
New York
–
HF
5
HRT Financial
New York
–